Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
04/03/1994 | CA2107514A1 Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides, processes for their preparation and their use as medicaments |
03/31/1994 | WO1994006916A1 Gene transcription and ionizing radiation: methods and compositions |
03/31/1994 | WO1994006789A1 Serotonin receptor agents |
03/31/1994 | WO1994006784A1 1,2-disubstituted ethyl amides as inhibitors of acat |
03/31/1994 | WO1994006761A1 Benzenealkanoic acids for cardiovascular diseases |
03/31/1994 | WO1994006457A1 Pharmaceutical formulations of interleukin-1 inhibitors |
03/31/1994 | WO1994006433A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
03/31/1994 | WO1994003421A3 Esters and combinations of an organic nitrate and a salicylate |
03/31/1994 | DE4244735A1 Medical use of C1 activator - to combat complications of therapy with cytokines, mediators or growth factors |
03/31/1994 | CA2145206A1 1,2-disubstituted ethyl amides as inhibitors of acat |
03/31/1994 | CA2107010A1 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz¬cd|indoles for treating motion sickness and vomiting |
03/30/1994 | EP0589491A1 Butenoic acid derivatives |
03/30/1994 | EP0589473A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and their use in pharmaceutical compositions |
03/30/1994 | EP0589446A1 N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors |
03/30/1994 | EP0589445A1 Renin Inhibiting N-(2-Amino-2-oxoethyl)Butanediamide Derivatives |
03/30/1994 | EP0589336A1 Benzoylguanidines, process for their preparation and their use as antiarrhythmic agents |
03/30/1994 | EP0589201A1 Di- and triazindeones |
03/30/1994 | EP0589037A1 Indian derivative and thromboxane antagonist containing the same |
03/30/1994 | EP0589018A1 Amines as inhibitors of squalene synthase |
03/30/1994 | EP0588839A1 Nitroglycerine plaster and process for making it. |
03/30/1994 | CN1084515A Phenyl sulfonamide endothelin antagonists |
03/30/1994 | CN1084409A Pharmaceutical compositions and uses therefor |
03/30/1994 | CN1084408A Cyclic adhesion inhibitors |
03/30/1994 | CA2106917A1 17-aryl and 17-heterocyclyl-5.beta.,14.beta.-androstane, derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
03/30/1994 | CA2106916A1 17-aryl and 17-heterocyclyl-14.beta.-5.alpha.-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
03/29/1994 | US5298616 Oligosaccharide contains a maximum of 6 monosaccharide units and at least one metal-sulfonate per monosaccharide unit |
03/29/1994 | US5298519 Acylals of imidazole-5-carboxylic acid derivatives, and their use as angiotensin (II) inhibitors |
03/29/1994 | US5298516 Treatment of cardiovascular disorders, angina |
03/29/1994 | US5298512 Substituted chromans and their use in the treatment of asthma, arthritis and related diseases |
03/29/1994 | US5298511 Alkanoic acid derivatives |
03/29/1994 | US5298506 Use of guanylate cyclase inhibitors in the treatment of shock |
03/29/1994 | US5298505 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
03/29/1994 | US5298503 Cardiovascular |
03/29/1994 | US5298496 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
03/29/1994 | US5298492 Inhibitors of endopeptidase and treatment of cardiovascular disorders |
03/29/1994 | CA1328113C Process for the manufacture of novel unsaturated amino acid compounds |
03/29/1994 | CA1328109C Hydroxybutenolide derivatives, production and use thereof |
03/29/1994 | CA1328105C Derivatized alkanolamines as cardiovascular agents |
03/29/1994 | CA1328076C Cerebral hyperkinemic composition containing a dihydropyridine derivative |
03/29/1994 | CA1328075C Ocular hypotensive agents |
03/26/1994 | CA2104748A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and method |
03/23/1994 | EP0588518A1 Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis |
03/23/1994 | EP0587814A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists |
03/23/1994 | EP0587767A1 Hydroxyazido derivatives and related compounds as renin inhibitors |
03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
03/23/1994 | EP0587698A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
03/23/1994 | EP0587673A1 Derivatives of thiopyranopyrrole and preparation thereof |
03/23/1994 | EP0587670A1 Pcp receptor ligands and the use thereof |
03/23/1994 | EP0587577A1 Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
03/23/1994 | EP0443047B1 Liquid nutrient composition |
03/23/1994 | CN1084172A Thiadiazinones |
03/23/1994 | CN1084166A Substituted (benzothiazolyl-and quinoxalyl-methoxy) phenyl-acetic acid derivatives |
03/23/1994 | CN1084162A Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use |
03/22/1994 | US5296509 Thioester enantiomeric compounds and their therapeutic uses |
03/22/1994 | US5296498 Guanidine compounds |
03/22/1994 | US5296494 Pyrrolidine compounds having thromboxane A2 receptor antagonistic activity and thromboxane A2 synthase inhibiting activity |
03/22/1994 | US5296492 Certain chroman derivatives useful for treating symptoms caused by contraction of smooth muscles, circulatory diseases or epilepsy |
03/22/1994 | US5296490 Pharmaceutically useful pyrazolopyridines |
03/22/1994 | US5296482 (Benzocycloalkyl) alkylamines |
03/22/1994 | US5296477 Aminoalkyl benzoxazine and benzthiazine compounds having a high 5-HT1A affinity |
03/22/1994 | US5296466 Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
03/22/1994 | CA1327971C Benzopyran compound and its pharmaceutical use |
03/22/1994 | CA1327969C Substituted amine derivatives, their production and use |
03/17/1994 | WO1994005777A1 Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
03/17/1994 | WO1994005677A1 Phosphono substituted tetrazole derivatives |
03/17/1994 | WO1994005661A1 Pyridopyrimidinone antianginal agents |
03/17/1994 | WO1994005660A1 Quinuclidine derivatives as squalene synthase inhibitors |
03/17/1994 | WO1994005659A1 Substituted thiazolidinedione derivatives |
03/17/1994 | WO1994005654A1 Heteroaryl compounds used as pharmaceuticals |
03/17/1994 | WO1994005531A1 Crank mechanism for a windscreen wiper drive of a motor vehicle |
03/17/1994 | WO1994005317A1 Methods for treating renin-related disorders with amylin antagonists |
03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
03/17/1994 | WO1994005305A1 Digitalis-like compounds |
03/17/1994 | WO1994005297A1 Drugs containing diphosphonic acids and salts thereof |
03/17/1994 | WO1994005275A1 Method of preventing nmda receptor-mediated neuronal damage |
03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
03/17/1994 | WO1993025568A3 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
03/17/1994 | WO1993025530A3 Vinyl arenas having retinoid-like activity |
03/17/1994 | EP0585366A4 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood. |
03/17/1994 | CA2273147A1 Substituted thiazolidinedione derivatives |
03/17/1994 | CA2144423A1 Heteroaryl compounds used as pharmaceuticals |
03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
03/17/1994 | CA2143653A1 Methods for treating renin-related disorders with amylin antagonists |
03/17/1994 | CA2143430A1 Quinuclidine derivatives as squalene synthase inhibitors |
03/17/1994 | CA2142348A1 Phosphono substituted tetrazole derivatives |
03/16/1994 | EP0587499A1 Benzopyran compounds, process for their preparation and their use as cell protectors |
03/16/1994 | EP0587377A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease |
03/16/1994 | EP0587188A2 Aryl and heterocyclic substituted propenamide derivatives |
03/16/1994 | EP0587180A2 Aryl urea (Thiourea) and cyanoguanidine derivatives |
03/16/1994 | EP0587134A2 Cyclic urea derivatives, medicaments containing them and process for their preparation |
03/16/1994 | EP0586909A2 Use of C1-inhibitor for the preparation of a medicament for the prophylaxes and therapy of the capillary leak syndroms and circulatory shock |
03/16/1994 | EP0586866A2 1,4,-Benzodioxane derivatives with pharmacologic properties |
03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
03/16/1994 | EP0586513A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
03/16/1994 | EP0586486A1 Derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them |
03/16/1994 | EP0586479A1 Dihydroxyindanone tyrosine kinase inhibitors |
03/16/1994 | EP0586466A1 Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same |
03/16/1994 | EP0586405A1 NOVEL 2H-BENZO b]PYRANE DERIVATIVES SUBSTITUTED IN THE 4 POSITION BY ARYL OR N-HETEROARYL, PROCESS FOR PRODUCING THEM AND PREPARATIONS CONTAINING THE COMPOUNDS. |
03/16/1994 | CN1083812A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
03/15/1994 | US5294724 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters and a process for their preparation |